Systematic review / meta-analysis / 2023
Bariatric surgery exhibited higher weight reduction and diabetes management efficacy than semaglutide, but carried a higher risk of complications.
A systematic review compared the efficacy and safety of semaglutide with bariatric surgery using data from trials including STEP, SUSTAIN, PIONEER, STAMPEDE, and the LABS consortium. Semaglutide demonstrated significant weight reduction, though adverse events included gastrointestinal disturbances, increased pulse rate, rare thyroid cancer cases, and partial weight regain after withdrawal. Bariatric surgery showed higher efficacy in weight reduction and diabetes management targets compared to medical therapy alone, but also carried a higher risk of complications.
- Study type
- Systematic review of clinical trials
- Who was studied
- Participants in clinical trials (e.g., STEP, SUSTAIN, PIONEER, STAMPEDE, LABS)
- What was measured
- Weight reduction, diabetes treatment targets, and adverse effects
THE PAPER
What Is Best for Weight Loss? A Comparative Review of the Safety and Efficacy of Bariatric Surgery Versus Glucagon-Like Peptide-1 Analogue.
Klair N, Patel U, Saxena A, Patel D, Ayesha IE, Monson NR, Ramphall S. Cureus, 2023.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.